VIR - Vir Biotechnology - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VIR is currently covered by 8 analysts with an average price target of $16.83. This is a potential upside of $11.89 (240.69%) from yesterday's end of day stock price of $4.94.

Vir Biotechnology's activity chart (see below) currently has 83 price targets and 83 ratings on display. The stock rating distribution of VIR is 23.33% HOLD and 76.67% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 53.48% with an average time for these price targets to be met of 150.08 days.

Highest price target for VIR is $110, Lowest price target is $14, average price target is $29.75.

Most recent stock forecast was given by JOSEPH STRINGER from NEEDHAM on 22-May-2025. First documented stock forecast 05-Nov-2019.

Currently out of the existing stock ratings of VIR, 7 are a HOLD (23.33%), 23 are a BUY (76.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$14

$9.42 (205.68%)

$14

3 months 7 days ago
(22-May-2025)

0/16 (0%)

$9.39 (203.69%)

Buy

$110

$105.42 (2301.75%)

6 months 1 days ago
(28-Feb-2025)

1/8 (12.5%)

$101.61 (1211.08%)

128

Hold

$14

$9.42 (205.68%)

$13

7 months 21 days ago
(08-Jan-2025)

3/7 (42.86%)

$1.52 (12.18%)

21

Buy

$20

$15.42 (336.68%)

$15

7 months 21 days ago
(08-Jan-2025)

1/4 (25%)

$7.52 (60.26%)

59

Buy

$26

$21.42 (467.69%)

$28

9 months 25 days ago
(04-Nov-2024)

3/8 (37.5%)

$16.63 (177.48%)

99

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VIR (Vir Biotechnology) average time for price targets to be met?

On average it took 150.08 days on average for the stock forecasts to be realized with a an average price target met ratio 53.48

Which analyst has the current highest performing score on VIR (Vir Biotechnology) with a proven track record?

ANUPAM RAMA

Which analyst has the most public recommendations on VIR (Vir Biotechnology)?

Anupam Rama works at JPMORGAN and has 6 price targets and 3 ratings on VIR

Which analyst is the currently most bullish on VIR (Vir Biotechnology)?

Patrick Trucchio with highest potential upside - $105.42

Which analyst is the currently most reserved on VIR (Vir Biotechnology)?

Michael Ulz with lowest potential downside - $7.42

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?